Literature DB >> 30288209

Correction: Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity.

D Maciejewska1, J Żabiński1, M Rezler1, P Kaźmierczak1, M S Collins2,3, L Ficker2,3, M T Cushion2,3.   

Abstract

[This corrects the article DOI: 10.1039/C7MD00445A.].

Entities:  

Year:  2017        PMID： 30288209      PMCID： PMC6144629          DOI： 10.1039/c7md90042b

Source DB:  PubMed          Journal:  Medchemcomm        ISSN： 2040-2503            Impact factor:   3.597


The authors regret that on page 7 of their article the name for compound 13 contains an error. The correct name for 13 is: 1,5-bis(4-amidino-2-nitrophenoxy)-3-oxapentane dihydrochloride (with -2- instead of -3-nitrophenoxy). The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
  1 in total

1.  Drug-likeness of linear pentamidine analogues and their impact on the hERG K+ channel - correlation with structural features.

Authors:  Teresa Żołek; Muge Qile; Paweł Kaźmierczak; Meye Bloothooft; Marcel A G van der Heyden; Dorota Maciejewska
Journal:  RSC Adv       Date:  2019-12-02       Impact factor: 3.361
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.